Literature DB >> 27986139

Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa.

Henri Montaudié1, Barbara Seitz-Polski2, Aurore Cornille2, Sylvia Benzaken2, Jean-Philippe Lacour1, Thierry Passeron3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27986139     DOI： 10.1016/j.jaad.2016.08.036

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  10 in total

1.  Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.

Authors:  Kristina Navrazhina; John W Frew; David Grand; Samuel C Williams; Hong Hur; Juana Gonzalez; Sandra Garcet; James G Krueger
Journal:  Br J Dermatol       Date:  2022-06-02       Impact factor: 11.113

Review 2.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

3.  What's Race Got to Do With It? CRP Levels in Immune Mediated Skin Diseases: Considerations for Hidradenitis Suppurativa.

Authors:  Chidubem A V Okeke; Jonathan P Williams; Callyn U Iwuala; Pearl K Igwe; Raveena Khanna; Jessica D Perry; Ginette A Okoye; Angel S Byrd
Journal:  Front Immunol       Date:  2022-03-29       Impact factor: 7.561

4.  Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.

Authors:  Samuel Der Sarkissian; Schapoor Hessam; Joslyn S Kirby; Michelle A Lowes; Dillon Mintoff; Haley B Naik; Hans Christian Ring; Nisha Suyien Chandran; John W Frew
Journal:  JAMA Dermatol       Date:  2022-03-01       Impact factor: 11.816

Review 5.  Hidradenitis suppurativa: an update on connecting the tracts.

Authors:  Mallory K Smith; Cynthia L Nicholson; Angela Parks-Miller; Iltefat H Hamzavi
Journal:  F1000Res       Date:  2017-07-28

Review 6.  TNF-α inhibitors in the treatment of hidradenitis suppurativa.

Authors:  Kevin T Savage; Kelsey S Flood; Martina L Porter; Alexa B Kimball
Journal:  Ther Adv Chronic Dis       Date:  2019-05-27       Impact factor: 5.091

Review 7.  Infliximab in hidradenitis suppurativa: A systematic review and meta-analysis.

Authors:  Terri Shih; Katrina Lee; Tristan Grogan; Devea R De; Vivian Y Shi; Jennifer L Hsiao
Journal:  Dermatol Ther       Date:  2022-07-18       Impact factor: 3.858

8.  Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers.

Authors:  A R J V Vossen; H H van der Zee; N Davelaar; A M C Mus; M B A van Doorn; E P Prens
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-12-10       Impact factor: 6.166

Review 9.  Hidradenitis suppurativa: infection, autoimmunity, or both?

Authors:  Costas A Constantinou; George E Fragoulis; Elena Nikiphorou
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-12-30       Impact factor: 5.346

Review 10.  Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis.

Authors:  Viktor A Zouboulis; Konstantin C Zouboulis; Christos C Zouboulis
Journal:  Pharmaceutics       Date:  2021-12-26       Impact factor: 6.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.